Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Clinical trial NCT06394518 · COMPLETED

Trial details

NCT number: NCT06394518
Sponsor: TenNor Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Prosthetic Joints Infection (PJI)

Start date: 2022-07-07
Primary completion: 2023-02-24
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.